By using the screener website, you consent to the data practices described in this statement.
Information Collected and How We Use It.
To determine whether you pre-qualify for a clinical trial for which we are identifying patients, or to identify a clinical research center in your area, we may ask you to provide us with information about yourself.
The personal information we collect includes your name, email address, and phone number, as well as certain other personal information, which may include health information, necessary to determine if you are an eligible candidate for this clinical trial.
We only seek personal and/or health information that is relevant to this clinical trial.
The information provided by you is stored on secured servers employing technology designed to maintain a secured environment. While all reasonable steps are taken to prevent unauthorized access, use, and alteration of personal information, we cannot guarantee the absolute security of such information. Please note that no method of transmission over the internet, or electronic storage, is 100 percent secure.
Your information will be released to the PPD call center if it is determined you may be an eligible candidate for the clinical trial in which you have expressed interest. It may also be accessed in part by other contracted and authorized parties that are working directly with PPD or the clinical trial sites.
Your personal information may be disclosed if and to the extent required by law, court order, or other governmental authority, and may be used or disclosed for the specific purposes for which it is collected and as authorized by law. As stated herein, your personal information (including your contact information) that you submit will be sent to the PPD call center if it appears you are an eligible candidate for the clinical trial. This occurs automatically after your submission of information; the screener website will automatically inform the PPD call center of your interest in participating in the clinical trial via email and or direct transfer.
Data Protection Laws.
Imperial Clinical Research Services participates in and has certified its compliance with the EU-U.S. Privacy Shield Framework. We are committed to subjecting all personal data received from European Union (EU) member countries (including Iceland, Norway and Lichtenstein), in reliance on the Privacy Shield Framework, to the Framework's applicable principles. To learn more about the Privacy Shield Framework, visit the U.S. Department of Commerce's Privacy Shield List: https://www.privacyshield.gov/list
Imperial Clinical Research Services is responsible for the processing of personal data it receives under the Privacy Shield Framework, and subsequently transfers to a third party acting as an agent on its behalf. We comply with the Privacy Shield Principles for all onward transfers of personal data from the EU, including the onward transfer liability provisions.
With respect to personal data received or transferred pursuant to the Privacy Shield Framework, Imperial Clinical Research Services is subject to the regulatory enforcement powers of the U.S. Federal Trade Commission. In certain situations, Imperial Clinical Research Services may be required to disclose personal data in response to lawful requests by public authorities, including to meet national security or law enforcement requirements.
In compliance with the Privacy Shield Principles, Imperial Clinical Research Services commits to resolve complaints about our collection or use of your personal information. European Union individuals with inquiries or complaints regarding our Privacy Shield policy should first contact Imperial Clinical Research Services utilizing one of the methods detailed under the Removing Your Information- "Inquiries, Complaints, and Requests to Exercise Rights" section of this policy.
If you have an unresolved privacy or data use concern that we have not addressed satisfactorily, please contact our independent dispute resolution mechanism, the BBB EU Privacy Shield, operated by the Council of Better Business Bureaus at https://www.bbb.org/EU-privacy-shield/for-eu-consumers for more information and to file a complaint. Under certain conditions, more fully described on the Privacy Shield website https://www.privacyshield.gov/article?id=How-to-Submit-a-Complaint, you may invoke binding arbitration before the Privacy Shield Panel when other dispute resolution procedures have been exhausted.
Information Retention Timelines.
All information collected by Imperial Clinical Research Services and/or its authorized agents will be kept on our secured servers until the conclusion of the study. Once the study has concluded, all potential patient information that was submitted as part of the online screening process will be destroyed, unless retention of such information was authorized prior to its submission.
Removing Your Information.
You may request to have your name removed from our database prior to its eventual destruction. In the event your information has already been passed to the PPD call center, you will need to contact them directly to remove your name from their database.
All requests to exercise informational rights and/or to remove your information from our database (e.g., access to data) or complaints should be addressed to:
- By email to firstname.lastname@example.org
- By fax to 616-802-5540, Attn: Privacy Officer
- By postal mail to Imperial Clinical Research Services, Inc., Attn: Privacy Officer, 3100 Walkent Drive NW, Grand Rapids, Michigan 49544 USA
*Please include your name, the study name, and the approximate date that you pre-qualified for the study.